Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction: Clinical Proof of Concept

Open access

Abstract

Long bone nonunion in the context of congenital pseudarthrosis or carcinologic resection (with intercalary bone allograft implantation) is one of the most challenging pathologies in pediatric orthopedics. Autologous cancellous bone remains the gold standard in this context of long bone nonunion reconstruction, but with several clinical limitations. We then assessed the feasibility and safety of human autologous scaffold-free osteogenic 3-dimensional (3D) graft (derived from autologous adipose-derived stem cells [ASCs]) to cure a bone nonunion in extreme clinical and pathophysiological conditions. Human ASCs (obtained from subcutaneous adipose tissue of 6 patients and expanded up to passage 4) were incubated in osteogenic media and supplemented with demineralized bone matrix to obtain the scaffold-free 3D osteogenic structure as confirmed in vitro by histomorphometry for osteogenesis and mineralization. The 3D "bone-like" structure was finally transplanted for 3 patients with bone tumor and 3 patients with bone pseudarthrosis (2 congenital, 1 acquired) to assess the clinical feasibility, safety, and efficacy. Although minor clones with structural aberrations (aneuploidies, such as tri or tetraploidies or clonal trisomy 7 in 6%-20% of cells) were detected in the undifferentiated ASCs at passage 4, the osteogenic differentiation significantly reduced these clonal anomalies. The final osteogenic product was stable, did not rupture with forceps manipulation, did not induce donor site morbidity, and was easily implanted directly into the bone defect. No acute (<3 mo) side effects, such as impaired wound healing, pain, inflammatory reaction, and infection, or long-term side effects, such as tumor development, were associated with the graft up to 4 years after transplantation. We report for the first time that autologous ASC can be fully differentiated into a 3D osteogenic-like implant without any scaffold. We demonstrated that this engineered tissue can safely promote osteogenesis in extreme conditions of bone nonunions with minor donor site morbidity and no oncological side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000002220

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Protocol to obtain a 3-dimensional (3D) osteogenic graft made of adipose-derived stem cells (ASCs). Human ASCs were isolated following digestion of subcutaneous adipose tissues, expanded up to passage 4 (P4), and finally differentiated in 2 phases. The osteogenic differentiation was induced to create a 3D structure by the addition of demineralized bone matrix (DBM). The optimal concentration of DBM was adjusted with the anticipated function of the 3D construction to produce a sufficiently stable graft for manipulation by forceps.
FIGURE 1 Protocol to obtain a 3-dimensional (3D) osteogenic graft made of adipose-derived stem cells (ASCs). Human ASCs were isolated following digestion of subcutaneous adipose tissues, expanded up to passage 4 (P4), and finally differentiated in 2 phases. The osteogenic differentiation was induced to create a 3D structure by the addition of demineralized bone matrix (DBM). The optimal concentration of DBM was adjusted with the anticipated function of the 3D construction to produce a sufficiently stable graft for manipulation by forceps.CC BY-NC-ND · PubMed Central
FIGURE 2 Genetic stability of ASCs in bone tumor context. Karyotype and FISH (FLI1-EWSR1 double fusion probe) analyses for the native tumor (A, arrow: t[11;22] [q24;q12]) and undifferentiated (B) and differentiated (C, arrow: t[14;15] [q32;q11.2]) ASC at P4 for patient 3: the FLI1-EWSR1 double fusion signals detected on the native tumour cells (A) were not detected in the ASCs at P4 (B, C), but minority tetrasomies of both probes by FISH suggesting tetraploidy were found for undifferentiated ASCs (B). Initial trisomy 8 was not detected, but minority tetraploidy (detected by the tetrasomies of both probes by FISH) was found after osteogenic differentiation (C) in comparison to the native tumor tissue. ASCs = adipose-derived stem cells, FISH = fluorescence in situ hybridization, P4 = passage 4.
FIGURE 2 Genetic stability of ASCs in bone tumor context. Karyotype and FISH (FLI1-EWSR1 double fusion probe) analyses for the native tumor (A, arrow: t[11;22] [q24;q12]) and undifferentiated (B) and differentiated (C, arrow: t[14;15] [q32;q11.2]) ASC at P4 for patient 3: the FLI1-EWSR1 double fusion signals detected on the native tumour cells (A) were not detected in the ASCs at P4 (B, C), but minority tetrasomies of both probes by FISH suggesting tetraploidy were found for undifferentiated ASCs (B). Initial trisomy 8 was not detected, but minority tetraploidy (detected by the tetrasomies of both probes by FISH) was found after osteogenic differentiation (C) in comparison to the native tumor tissue. ASCs = adipose-derived stem cells, FISH = fluorescence in situ hybridization, P4 = passage 4.CC BY-NC-ND · PubMed Central
FIGURE 3 Bone defect at the junction between the native bone tissue and the intercalary allograft (after tumor resection at the right tibia). A, No patient had complications during follow-up, but patient #2 underwent allograft removal because of intercalary allograft infection more than 10 months posttransplantation. No long-term complications were observed for patients 1 and 3 after a mean follow-up of 37 months. B, The graft was placed at the direct junction between both tissues without any fixation material. The total consolidation was demonstrated at 24.3 months, the total bridge between the native tissue and the allograft was confirmed at 33 months postimplantation (as demonstrated by nuclear magnetic resonance), and the consolidation is currently maintained up to 47 months posttransplantation. A complete return to normal quality of life for patient #3 was confirmed after 3 years.
FIGURE 3 Bone defect at the junction between the native bone tissue and the intercalary allograft (after tumor resection at the right tibia). A, No patient had complications during follow-up, but patient #2 underwent allograft removal because of intercalary allograft infection more than 10 months posttransplantation. No long-term complications were observed for patients 1 and 3 after a mean follow-up of 37 months. B, The graft was placed at the direct junction between both tissues without any fixation material. The total consolidation was demonstrated at 24.3 months, the total bridge between the native tissue and the allograft was confirmed at 33 months postimplantation (as demonstrated by nuclear magnetic resonance), and the consolidation is currently maintained up to 47 months posttransplantation. A complete return to normal quality of life for patient #3 was confirmed after 3 years.CC BY-NC-ND · PubMed Central
FIGURE 4 Bone nonunion in a case of congenital pseudarthrosis. A, No acute complication was reported for patients with bone nonunion (patients 4–6), 1 case required material removal due to sepsis following screw and plate infection by Staphylococcus aureus at 10 months posttransplantation. No sign of bone consolidation was found. For patient #4, a surgical revision was performed at 9 months, due to incomplete or inefficient bone consolidation. In bone nonunion within an erythroblastopenia context, the bone consolidation was confirmed at 10 months postimplantation and maintained up to 29.8 months. B, The 3D graft can easily be placed in the large bone defect of the left ulna of patient 4. Bone nonunion, found on the right tibia of patient 6, was initiated at 6 months postimplantation and consolidated up to 29.8 months. 3D = 3-dimensional.
FIGURE 4 Bone nonunion in a case of congenital pseudarthrosis. A, No acute complication was reported for patients with bone nonunion (patients 4–6), 1 case required material removal due to sepsis following screw and plate infection by Staphylococcus aureus at 10 months posttransplantation. No sign of bone consolidation was found. For patient #4, a surgical revision was performed at 9 months, due to incomplete or inefficient bone consolidation. In bone nonunion within an erythroblastopenia context, the bone consolidation was confirmed at 10 months postimplantation and maintained up to 29.8 months. B, The 3D graft can easily be placed in the large bone defect of the left ulna of patient 4. Bone nonunion, found on the right tibia of patient 6, was initiated at 6 months postimplantation and consolidated up to 29.8 months. 3D = 3-dimensional.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 66

Metadata

Authors
Dufrane, D., Docquier, P.-L., Delloye, C., Poirel, H. A., André, W., & Aouassar, N.
Affiliations
Cliniques Universitaires Saint-Luc (BE)
Corresponding author
Dufrane, Denis
Venue
Medicine
Published
2015-12
Volume
94
Issue
50
Pages
e2220
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2314226316
Cited by
66
References
41
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 6
FWCI
2.82
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (submittedVersion, other-oa)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
Keywords
adipose-derived stem cells, osteogenic differentiation, long bone nonunion, congenital pseudarthrosis, bone tumor resection, demineralized bone matrix, donor site morbidity, bone defect repair, pediatric orthopedics
MeSH terms
Adolescent, Bone Neoplasms, Cell Differentiation, Child, Feasibility Studies, Female, Humans, Male, Pseudarthrosis, Osteosarcoma, Stem Cells, Adipocytes, Tissue Engineering, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction: Clinical Proof of Concept. https://app.cochat.ai/papers/10.1097/md.0000000000002220
The paper
Dufrane, D., Docquier, P.-L., Delloye, C., Poirel, H. A., André, W., & Aouassar, N. (2015). Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction: Clinical Proof of Concept. Medicine. https://doi.org/10.1097/md.0000000000002220

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.